SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response

Between June and November 2020, we assessed plasma antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid protein in 4996 participants (aged 18–82 years, 34.5% men) from the National and Kapodistrian University of Athens. The weighted overall prevalence was 1.6%...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsitsilonis, Ourania E., Paraskevis, Dimitrios, Lianidou, Evi, Terpos, Evangelos, Akalestos, Athanasios, Pierros, Vassilios, Kostaki, Evangelia Georgia, Kastritis, Efstathios, Moutsatsou, Paraskevi, Politou, Marianna, Scorilas, Andreas, Sphicopoulos, Thomas, Thomaidis, Nikolaos, Trougakos, Ioannis P., Tsakris, Athanassios, Voulgaris, Nikolaos, Daskalaki, Christina C., Evangelakou, Zoi, Fouki, Christina, Gianniou, Despoina D., Gumeni, Sentiljana, Kostopoulos, Ioannis V., Manola, Maria S., Orologas-Stavrou, Nikolaos, Panteli, Chrysanthi, Papanagnou, Eleni-Dimitra, Rousakis, Pantelis, Sklirou, Aimilia D., Smilkou, Stavroula, Stergiopoulou, Dimitra, Tsiodras, Sotirios, Dimopoulos, Meletios-Athanasios, Sfikakis, Petros P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998869/
https://www.ncbi.nlm.nih.gov/pubmed/33801380
http://dx.doi.org/10.3390/vaccines9030207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998869/
https://www.ncbi.nlm.nih.gov/pubmed/33801380
http://dx.doi.org/10.3390/vaccines9030207

Ejemplares similares